PUBLICATIONS FROM THE FINNISH CANCER REGISTRY 1953-2016 by K. Talala 20.09.2016
Kaapu, K.J., Murtola, T.J., Määttänen, L., Talala, K., Taari, K., Tammela, T.L.J. and Auvinen, A.: Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial. Cancer Causes Control 2016; 27: 157-164.
Murtola, T.J., Karppa, E.K., Taari, K., Talala, K., Tammela, T.L.J. and Auvinen, A.: 5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial. Int. J. Cancer 2016; 138: 2820-2828.
Pashayan, N., Pharoah, P.D.P., Schleutker, J., Talala, K., Tammela, T.L.J., Määttänen, L., Harrington, P., Tyrer, J., Eeles, R., Duffy, S.W. and Auvinen, A.: Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br. J. Cancer 2015; 113: 1086-1093.